Saw Palmetto is used in the Men’s Formula of the CardioTrim health supplement line.

References:

1. Bauer HW, Casarosa C, Cosci M, Fratta M, Blessmann G. Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study. MMW Fortschr Med. 1999 Jun 24;141(25):62.
2. Bracher F. Phytotherapy of benign prostatic hyperplasia. Urologe A. 1997 Jan;36(1):10-7.
3. de la Taille A, Hayek OR, Burchardt M, Burchardt T, Katz AE. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports. J Altern Complement Med. 2000 Oct;6(5):449-51.
4. Dreikorn K, Schonhofer PS. Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia. Urologe A. 1995 Mar;34(2):119-29.
5. Ernst E. Herbal medications for common ailments in the elderly. Drugs Aging. 1999 Dec;15(6):423-8.
6. Gerber G. What is saw palmetto used for, and does it interact with any medications? Health News. 2000 Jun;6(6):10.
7. Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology. 1998 Jun;51(6):1003-7.
8. Gerber GS. Saw palmetto for the treatment of men with lower urinary tract symptoms. J Urol. 2000 May;163(5):1408-12.
9. Glisson J, Crawford R, Street S. The clinical applications of Ginkgo biloba, St. John's wort, saw palmetto, and soy. Nurse Pract. 1999 Jun;24(6):35-6.
10. Goepel M, Hecker U, Krege S, Rubben H, Michel MC. Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro. Prostate. 1999 Feb 15;38(3):208-15.
11. Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, deKernion JB. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol. 2000 May;163(5):1451-6.
12. Marks LS, Tyler VE. Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia. Urology. 1999 Mar;53(3):457-61.
13. McKinney DE. Saw palmetto for benign prostatic hyperplasia. JAMA. 1999 May 12;281(18):1699.
14. McPartland JM, Pruitt PL. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study. J Am Osteopath Assoc. 2000 Feb;100(2):89-96.
15. Ondrizek RR, Chan PJ, Patton WC, King A. Inhibition of human sperm motility by specific herbs used in alternative medicine. J Assist Reprod Genet. 1999 Feb;16(2):87-91.
16. Porterfield H. UsToo PC-SPES surveys: review of studies and update of previous survey results. Mol Urol. 2000 Fall;4(3):289-92.
17. Powers JE. That pesky prostate and the saw palmetto. S D J Med. 1997 Dec;50(12):453-4.
18. Schilcher H. Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens. Wien Med Wochenschr. 1999;149(8-10):236-40.
19. Segars LW. Saw palmetto extracts for benign prostatic hyperplasia. J Fam Pract. 1999 Feb;48(2):88-9.
20. Shimada H, Tyler VE, McLaughlin JL. Biologically active acylglycerides from the berries of saw-palmetto (Serenoa repens). J Nat Prod. 1997 Apr;60(4):417-8.
21. Sokeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU Int. 2000 Sep;86(4):439-42.
22. Swoboda H, Kopp B. Serenoa repens--the saw palmetto or dwarf palm. Wien Med Wochenschr. 1999;149(8-10):235.
23. Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA. 1998 Nov 11;280(18):1604-9.